CI
TECH icon

CX Institutional’s Bio-Techne TECH Stock Holding History

CX Institutional’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
4,807
+857
+22% +$46.3K 0.01% 582
2026
Q1 		$206K Sell
3,950
-45
-1% -$2.7K 0.01% 709
2025
Q4 		$235K Buy
3,995
+806
+25% +$49K 0.01% 653
2025
Q3 		$177K Buy
3,189
+118
+4% +$6.32K 0.01% 728
2025
Q2 		$158K Buy
3,071
+2,612
+569% +$131K 0.01% 689
2025
Q1 		$27K Buy
+459
New +$31.1K ﹤0.01% 922
2022
Q3 		– Sell
-52
Closed -$5K – 1061
2022
Q2 		$5K Buy
+52
New +$4.87K ﹤0.01% 1040
2021
Q4 		– Sell
-28
Closed -$3K – 833
2021
Q3 		$3K Hold
28
– – ﹤0.01% 889
2021
Q2 		$3K Hold
28
– – ﹤0.01% 891
2021
Q1 		$3K Hold
28
– – ﹤0.01% 818
2020
Q4 		$2K Hold
28
– – ﹤0.01% 829
2020
Q3 		$2K Buy
28
+4
+17% +$260 ﹤0.01% 822
2020
Q2 		$2K Buy
+24
New +$1.44K ﹤0.01% 768

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CX Institutional's TECH Position: Q2 2026 in Review

CX Institutional increased its Bio-Techne (TECH) stake by 22% in Q2 2026, buying an estimated $46.3K and bringing the position to 4,807 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #582.

CX Institutional first reported a position in TECH in Q2 2020 and has held it in 13 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • CX Institutional held 4,807 shares of Bio-Techne worth $340K as of Q2 2026.
  • CX Institutional bought 857 Bio-Techne shares in Q2 2026, an estimated $46.3K.
  • Bio-Techne made up 0.01% of CX Institutional's portfolio in Q2 2026, its #582 holding.
  • CX Institutional first reported a position in Bio-Techne in Q2 2020 and has held it in 13 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.